October 30, 2017
Biophytis has FDA Approval to initiate SARA-INT phase 2b Interventional Study of Sarconeos in Sarcopenia. Read the Press Release
Biophytis
LIVE HEALTHIER LONGER
Biophytis has FDA Approval to initiate SARA-INT phase 2b Interventional Study of Sarconeos in Sarcopenia. Read the Press Release